Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.50 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract

Fri, 16th Apr 2021 11:28

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

AFC Energy PLC - Surrey, England-based provider of hydrogen power generation technologies - Raises GBP36 million from oversubscribed fundraising of 48.4 million shares placed at 64.5 pence and a further 5.0 million shares offered for subscription to ABB Schweiz AG at the same price as the placing and 2.3 million shares subscribed for by Dutco group. The net proceeds from the raising will be used to support the continued product development of AFC Energy and ABB's next generation high power sustainable electric vehicle charging solutions. It will also go towards the development of new power solutions utilising AFC Energy's alkaline fuel cell technology platform, including the high growth global data centre market in collaboration with ABB. Finally, the continued development of the company's scalable manufacturing capacity to address possible future growth in system demand. Separately, signs new agreement with ABB to extend its partnership to now include the global data centre market, which currently consumes about 2% of worldwide power demand.

----------

Accsys Technologies PLC - wood building products manufacturer - Notes strong sales and revenue growth in the second half of the year ended March 31 following the "rapid recovery" after the initial Covid-19 hit in the first quarter. Expects Accoya unit to post revenue of about EUR91 million, up 10% on year before with 23% year on year growth in second half. Group revenue to be about EUR98 million versus EUR94.1 million year before. Annual sales volume expected about 4% higher at 60,466 cubic metres. Notes production has continued at capacity levels throughout the second half driven by ongoing strong demand from new and existing customers. Will now focus on rebuilding inventory stock levels, which are lower than usual. Chief Executive Rob Harris says: "We have delivered a strong 12 months during which we have grown revenues, profits and preserved cash by successfully managing the revenue, margin and cost challenges presented by Covid-19. This strong performance reflects the agility of our business and the underlying demand for our sustainable products as the world further focuses on decarbonisation."

----------

Angle PLC - Guildford-based liquid biopsy company - Secures first large-scale pharma services contract. The customer, an unnamed pharma company with numerous cancer drugs under development and annual revenues exceeding USD1 billion, has selected company's Parsortix system to undertake longitudinal monitoring of patients in three separate global clinical trials in prostate cancer and other locally advanced and metastatic solid tumours. The contract is expected to be worth up to USD1.2 million over some 18 months. The work relates to a large Phase III prostate cancer study and two smaller Phase I studies. The Phase I studies, if successful, could progress to larger Phase II studies and, if successful, much larger Phase III studies.

----------

Zoetic International PLC - London-based cannabidiol products company - Reports rollout of its Chill brand of tobacco alternative products continues at "considerable speed". Since end of October, further orders have been placed by major distribution partners as the brand expands across the US towards full commercialisation. By July 2021, it is expected that Chill products will be on sale in 3,500 high footfall outlets. "This rollout will continue to ramp up over the course of the next 10 to 12 months and the information gathered during this initial phase will allow Zoetic to guide its strategy," company adds. Expects Chill to be available in UK during second quarter. Co-Chief Executive Trevor Taylor says this is "busy and exciting time".

----------

Immunodiagnostic Systems Holdings PLC - Tyne & Wear-based diagnostic testing kits and instruments maker - Trading in second half of year recovered strongly from a pandemic-hit first half. Revenue in final six months to March 31 to be at GBP19.0 million, up 39% from GBP13.7 million in the first half. Annual revenue is expected at GBP32.7 million, down from GBP39.3 million the year before. "The development of the Automated Business strongly correlates with the placement of new instruments, as each new instrument generates recurring incremental revenues. Therefore, we are pleased to report that instrument placements-sales in our Automated Business unit were 79 during the second half, compared to 61 the year before, bringing full year placements-sales to 100, up from 93 year on year. This rate of placements represents the strongest performance in eight years," company adds. Very confident of revenue growth in Automated Business going forward.

----------

Caspian Sunrise PLC - oil and gas in Kazakhstan - Notes price for oil sold to the domestic market from its flagship BNG Contract Area has been increased to approximately USD12.4 per barrel. "While this still lags far behind the international price it is approximately double the price received for most of the past 12 months and as such will be a significant boost for the company's finances," company adds. Chair Clive Carver says news is "very welcome".

----------

Grafenia PLC - Manchester-based printing business - Says many of clients in hospitality, retail, sports and events have been closed since December 2020, or earlier, which has hurt revenues. Expects to report annual revenue for year ended March 31 of GBP9.5 million, down from GBP15.6 million year before. "Whilst that's a significant fall in product sales, income from subscription fees and services was steadier," company adds. Expects to report gross profit of about GBP5.6 million, down from GBP8.0 million. "Trading in January and February this year was the most challenging. As winter turned to spring, revenue in March 2021 improved and was 80% of the same period last year. This April has started well, as businesses in England begin to pull up the shutters and prepare to re-open. Given that last April, the whole country was watching Tiger King in the first lockdown, it shouldn't be difficult to beat last year's performance," company adds. Reorganises internal reporting to simplify group structure, will now start reporting as two independent businesses: Works Manchester and Nettl Systems.

----------

Iconic Labs PLC - UK-based media and technology business - Following settlement agreement with European High Growth Opportunities Securitization Fund, notes EHGOF now withdraws claim of alleged breaches of various finance agreements between the two firms. Previously agrees to be bound by the agreements previously entered into with the fund, issue an additional 80 convertible notes - equivalent to GBP800,000 - together with an appropriate number of warrants under the terms of the finance agreements, and buy back any warrants where Iconic Labs has insufficient corporate authorities to issue shares. As a result, company says Friday that EHGOF has also indicated its willingness to enter into discussions regarding a finance facility of up to GBP50 million to support the company's growth plans, it says. Brad Taylor, chief executive of Iconic Labs said: "We are excited about our ambitious acquisition and growth plans and look forward to discussing these plans further with EHGOF."

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jun 2022 20:13

IN BRIEF: Angle's Parsortix performs well on prostate cancer patients

Angle PLC - Surrey, England-based medical diagnostics company - Notes researchers at King's College London published data investigating the role of invasive cellular protrusion, known as invadopodia, activity in prostate cancer, and a potential role in the formation of circulating tumour cells. Researchers used Angle's Parsortix system's ability to isolate CTCs from the blood of prostate cancer patients. Parsortix system isolates CTCs in 94% of prostate cancer patients, showing some association with matrix degradation and invasive cellular protrusion formation. This may allow novel therapeutic development targeting the mechanisms of invadopodia and reducing metastatic spread of the cancer, it says.

Read more
30 May 2022 15:21

IN BRIEF: Angle partners with US urology group for Parasortix study

Angle PLC - Surrey, England-based medical diagnostics company - Establishes partnership with MidLantic Urology to evaluate the use of its Parasortix system in prostate cancer clinical studies. MidLantic is as an affiliate of special urology services provider Solaris, which has over 500 clinical urology providers across 179 locations in the US, with over 729,000 annual patients. Angle hopes the collaboration will "enable potential sales" to Solaris' patient base. The first study is expected to start in the third quarter of 2022, with results to be available in 2023.

Read more
27 May 2022 21:25

TRADING UPDATES: Savannah Energy to develop new projects in Chad

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 May 2022 21:19

IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval

Angle PLC - Surrey, England-based medical diagnostics company - Receives approval from the US Food & Drug Administration for the use of its Parasortix system for use in metastatic breast cancer patients. Parasortix isolates circulating tumour cells from the blood which can aid in the diagnosis, characterisation and monitoring of cancer, and do so in a much less invasive fashion than traditional tissue biospy.

Read more
25 May 2022 17:06

LONDON MARKET CLOSE: Stocks rise ahead of US Fed meeting minutes

(Alliance News) - Stocks in London ended mostly higher on Wednesday as market participants look ahead to the latest minutes from the US Federal Reserve at 1900 BST.

Read more
20 May 2022 13:07

Angle's Parsortix to be used in 'significant' prostate cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that Prostate Cancer UK has approved funding for a "significant" clinical study at the Barts Cancer Institute of the Queen Mary University of London.

Read more
20 May 2022 09:48

IN BRIEF: Cancer study using Angle's Parasortix secures funding

Angle PLC - Surrey, England-based medical diagnostics company - Says Prostate Cancer UK has given a GBP750,000 grant for a clinical study at Barts Cancer Institute, Queen Mary University of London. The trial will follow 200 men with localised prostate cancer over five years, assessed using Angle's Parsortix system, in bid to see whether the cancer will eventually spread.

Read more
28 Apr 2022 16:10

EARNINGS UPDATES: Brave Bison notes first profit; Angle widens loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Apr 2022 16:10

UK earnings, trading statements calendar - next 7 days

Friday 22 April 
Alphawave IP Group PLCFull Year Results
Petropavlovsk PLCTrading Statement
Record PLCTrading Statement
Serabi Gold PLCFull Year Results
Zinc Media Group PLCFull Year Results
Monday 25 April 
Access Intelligence PLCFull Year Results
Arecor Therapeutics PLCFull Year Results
Audioboom Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Chapel Down Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Vector Capital PLCFull Year Results
Tuesday 26 April 
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Billington Holdings PLCFull Year Results
Corero Network Security PLCFull Year Results
Focusrite PLCHalf Year Results
Futura Medical PLCFull Year Results
Gaming Realms PLCFull Year Results
Hochschild Mining PLCTrading Statement
HSBC Holdings PLCQ1 Results (at 0500 BST)
Immotion Group PLCFull Year Results
IWG PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Learning Technologies Group PLCFull Year Results
Loungers PLCTrading Statement
National Express Group PLCTrading Statement
Northcoders Group PLCFull Year Results
Nostrum Oil & Gas PLCFull Year Results
PureTech Health PLCFull Year Results
RWS Holdings PLCHalf Year Results
Taylor Wimpey PLCFull Year Results
Wednesday 27 April 
1Spatial PLCFull Year Results
AB Dynamics PLCHalf Year Results
Anglo Pacific Group PLCQ1 Results
Aveva Group PLCTrading Statement
City Pub Group PLCFull Year Results
Drax Group PLCTrading Statement
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
Go-Ahead Group PLCHalf Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
Network International Holdings PLCTrading Statement
Nichols PLCFull Year Results
Persimmon PLCTrading Statement
Primary Health Properties PLCTrading Statement
RPS Group PLCQ1 Results
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Yamana Gold IncTrading Statement
Thursday 28 April 
Angle PLCFull Year Results
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
C4X Discovery Holdings PLCHalf Year Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCTrading Statement
Howden Joinery Group PLCTrading Statement
HSS Hire Group PLCFull Year Results
Hurricane Energy PLCFull Year Results
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
International Personal Finance PLCTrading Statement
J Sainsbury PLCFull Year Results
Keystone Law Group PLCFull Year Results
Lancashire Holdings LtdQ1 Trading Statement
Novacyt SAFull Year Results
PPHE Hotel Group LtdTrading Statement
Sanderson Design Group PLCFull Year Results
Schroders PLCTrading Statement
Smith & Nephew PLCQ1 Results
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Standard Chartered PLCQ1 Results
Unilever PLCQ1 Results
Whitbread PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Apr 2022 12:25

TRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt tops forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Mar 2022 19:29

IN BRIEF: Angle's Parsortix can help with cancer treatment options

Angle PLC - Surrey, England-based medical diagnostics company - Notes University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute has published results of work undertaken in preclinical models of triple-negative breast cancer. Findings show isolation of live circulating tumour cells from a simple blood draw, using Angle's Parsortix system, can provide rapid information on patient response to existing chemotherapy treatments that can target metastasis more effectively than tumour growth.

Read more
25 Mar 2022 18:51

TRADING UPDATES: Europa eyes fundraise; Eastinco extends long stop

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Mar 2022 20:38

TRADING UPDATES: Angle US lab boost; Corcel to capitalise on nickel

(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News:

Read more
24 Jan 2022 09:36

LONDON BROKER RATINGS: Jefferies cuts Berkeley, Barratt and Bellway

LONDON BROKER RATINGS: Jefferies cuts Berkeley, Barratt and Bellway

Read more
21 Jan 2022 10:57

Study shows potential for Angle's Parsortix system in clinical trials

Study shows potential for Angle's Parsortix system in clinical trials

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.